Opportunity ID: 334284

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-250
Funding Opportunity Title: Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 22, 2021
Last Updated Date: Jun 22, 2021
Original Closing Date for Applications: Sep 07, 2024
Current Closing Date for Applications: Sep 07, 2024
Archive Date: Oct 13, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Small businesses
State governments
Special district governments
Public and State controlled institutions of higher education
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) focuses on sensitivity and tolerance mechanisms underlying the development of alcohol use disorder. The intent of this FOA is to: (1) develop hypotheses about cellular, molecular or network mechanisms that regulate sensitivity and tolerance to alcohol, and (2) develop quantitative models to predict the development of tolerance and the progression to alcohol use disorder. These objectives will be accomplished with a Phased Innovation (R21/R33) mechanism, clinical trial optional, in which secondary data analysis or pilot studies can occur during the R21 phase, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R21 phase.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-250.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 334284 Full Announcement-PAR-21-250 -> PAR-21-250-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00270314 Nov 16, 2021 Jan 24, 2023 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00267857 Sep 16, 2021 Jan 24, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278355 Nov 14, 2022 Sep 07, 2024 View

Package 1

Mandatory forms

334284 RR_SF424_5_0-5.0.pdf

334284 PHS398_CoverPageSupplement_5_0-5.0.pdf

334284 RR_OtherProjectInfo_1_4-1.4.pdf

334284 PerformanceSite_4_0-4.0.pdf

334284 RR_KeyPersonExpanded_4_0-4.0.pdf

334284 RR_Budget_3_0-3.0.pdf

334284 PHS398_ResearchPlan_4_0-4.0.pdf

334284 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334284 RR_SubawardBudget30_3_0-3.0.pdf

334284 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

334284 RR_SF424_2_0-2.0.pdf

334284 PHS398_CoverPageSupplement_5_0-5.0.pdf

334284 RR_OtherProjectInfo_1_4-1.4.pdf

334284 PerformanceSite_2_0-2.0.pdf

334284 RR_KeyPersonExpanded_2_0-2.0.pdf

334284 RR_Budget_1_4-1.4.pdf

334284 PHS398_ResearchPlan_4_0-4.0.pdf

334284 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

334284 RR_SubawardBudget30_1_4-1.4.pdf

334284 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

334284 RR_SF424_5_0-5.0.pdf

334284 PHS398_CoverPageSupplement_5_0-5.0.pdf

334284 RR_OtherProjectInfo_1_4-1.4.pdf

334284 PerformanceSite_4_0-4.0.pdf

334284 RR_KeyPersonExpanded_4_0-4.0.pdf

334284 RR_Budget_3_0-3.0.pdf

334284 PHS398_ResearchPlan_5_0-5.0.pdf

334284 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334284 RR_SubawardBudget30_3_0-3.0.pdf

334284 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T12:18:27-05:00

Share This Post, Choose Your Platform!

About the Author: